Read More 1 minute read Funding News News Therapeutics Halda Therapeutics Secures $126M to Advance Novel RIPTAC Cancer Therapies Key Highlights Halda Therapeutics raises $126M in Series B extension, total $202M funding to date. Proceeds will advance… byChris-Anne RoqueAugust 15, 2024
Read More 1 minute read Funding News News Therapeutics Capstan Therapeutics Secures $175M in Series B Key Highlights $175M Series B financing led by RA Capital Management with broad investor participation. Funds to advance CPTX2309, Capstan’s… byChris-Anne RoqueMarch 25, 2024